Suppr超能文献

靶向乙肝cccDNA水平:实现慢性乙型肝炎完全治愈的关键

Targeting HBV cccDNA Levels: Key to Achieving Complete Cure of Chronic Hepatitis B.

作者信息

He Wei, Zheng Zhijin, Zhao Qian, Zhang Renxia, Zheng Hui

机构信息

Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou 215123, Jiangsu, China.

MOE Key Laboratory of Geriatric Disease and Immunology of Ministry of Education of China, Collaborative Innovation Center of Hematology, International Institute of Infection and Immunity, Institutes of Biology and Medical Sciences (IBMS), School of Medicine, Soochow University, Suzhou 215123, Jiangsu, China.

出版信息

Pathogens. 2024 Dec 13;13(12):1100. doi: 10.3390/pathogens13121100.

Abstract

Chronic hepatitis B (CHB) caused by HBV infection has brought suffering to numerous people. Due to the stable existence of HBV cccDNA, the original template for HBV replication, chronic hepatitis B (CHB) is difficult to cure completely. Despite current antiviral strategies being able to effectively limit the progression of CHB, complete CHB cure requires directly targeting HBV cccDNA. In this review, we discuss strategies that may achieve a complete cure of CHB, including inhibition of cccDNA de novo synthesis, targeting cccDNA degradation through host factors and small molecules, CRISP-Cas9-based cccDNA editing, and silencing cccDNA epigenetically.

摘要

由乙肝病毒(HBV)感染引起的慢性乙型肝炎(CHB)给众多人带来了痛苦。由于HBV共价闭合环状DNA(cccDNA)这一HBV复制的原始模板稳定存在,慢性乙型肝炎(CHB)难以被完全治愈。尽管目前的抗病毒策略能够有效限制CHB的进展,但彻底治愈CHB需要直接靶向HBV cccDNA。在这篇综述中,我们讨论了可能实现CHB彻底治愈的策略,包括抑制cccDNA的从头合成、通过宿主因子和小分子靶向cccDNA降解、基于CRISP-Cas9的cccDNA编辑以及对cccDNA进行表观遗传沉默。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e3/11728772/54c71b2f2ed3/pathogens-13-01100-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验